FIELD: medicine; obstetrics.
SUBSTANCE: invention can be used to predict early preeclampsia according to the level of procoagulant activity of tissue factor in blood plasma at 19–21 weeks of gestation in patients of the low-risk group. If the level of procoagulant activity of tissue factor (TF) is greater than or equal to 14.74 pmol/liter, a high risk of developing early preeclampsia is predicted.
EFFECT: method provides the possibility of predicting the development of early preeclampsia in patients of a low-risk group, allowing timely stratification of pregnant women into a group for additional examination methods and preventive measures, by determining the level of procoagulative activity of TF in blood plasma at 19–21 weeks of gestation, during the second ultrasound screening for patients at low risk of developing preeclampsia.
1 cl, 2 dwg, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PREDICTION OF PLACENTAL PREECLAMPSIA ACCORDING TO PLACENTOMETRY AT GESTATION 19-21 WEEKS IN LOW-RISK PATIENTS | 2021 |
|
RU2771762C1 |
| METHOD OF PREDICTING THE RECURRENCE OF EARLY SEVERE PREECLAMPSIA BASED ON THE RESULTS OF A STUDY OF THE LEVEL OF PLACENTAL MICROVESICLES IN BLOOD PLASMA IN PATIENTS WITH SEVERE PREECLAMPSIA IN A PERSONAL HISTORY | 2022 |
|
RU2798715C1 |
| METHOD FOR PREDICTING THE RECURRENCE OF EARLY PREECLAMPSIA BY MARKERS OF ENDOTHELIAL DYSFUNCTION | 2022 |
|
RU2795090C1 |
| METHOD FOR PREDICTION OF RISK OF DEVELOPING PREECLAMPSIA | 2023 |
|
RU2817206C1 |
| METHOD FOR PREDICTING EFFECTIVENESS OF TREATMENT OF MODERATE PREECLAMPSIA | 2020 |
|
RU2752715C1 |
| METHOD FOR FORECASTING SEVERITY OF EARLY PREECLAMPSY | 2021 |
|
RU2753463C1 |
| METHOD FOR PREDICTING THE EFFECTIVENESS OF THE TREATMENT OF MODERATE PREECLAMPSIA | 2019 |
|
RU2705374C1 |
| METHOD OF PREDICTING THE DEVELOPMENT OF HYPERTENSIVE DISORDERS DURING PREGNANCY IN THE MIDDLE RISK GROUP AMONG THE WOMEN WHO UNDERWENT COMBINED SCREENING OF THE 1ST TRIMESTER | 2023 |
|
RU2803010C1 |
| METHOD FOR PREDICTING THE RISK OF PREECLAMPSIA IN PREGNANT WOMEN WITH TYPE 1 AND TYPE 2 DIABETES MELLITUS | 2020 |
|
RU2751139C1 |
| METHOD FOR PREDICTING THE RISK OF DEVELOPING PREECLAMPSIA IN WOMEN BASED ON GENETIC MARKERS | 2022 |
|
RU2795660C1 |
